BOSTON – Dr. Kingsley R. Chin, 61, the founder, president, and CEO of Massachusetts-based medical device company SpineFrontier, Inc., is facing the consequences for a calculated scheme to mislead federal regulators. Yesterday, U.S. District Court Judge Indira Talwani sentenced Chin to one year of supervised release, with the first six months to be served under home confinement. This isn’t just a slap on the wrist, though; the financial penalties are substantial.
Chin pleaded guilty in May 2025 to one count of false statements. The core of the deception revolved around the Physician Payment Sunshine Act, a law requiring device manufacturers to publicly disclose payments and “transfers of value” made to physicians, including those performing spine surgeries. This data is meticulously tracked by the Centers for Medicare & Medicaid Services (CMS) via the Open Payments website, ensuring transparency in healthcare financial relationships.
The scheme, as laid out in court documents, involved SpineFrontier offering surgeons “consulting” opportunities, but the work was largely a sham. Chin directed his employees to falsely categorize payments as legitimate consulting fees, even when no actual consulting services were rendered. On January 19, 2016, a $4,750 payment to a surgeon was deliberately reported as a “consulting” fee despite Chin’s knowledge that no consulting had taken place. This wasn’t an isolated incident, but a deliberate attempt to obscure the true nature of these financial transactions.
The sentencing isn’t solely focused on Chin. As part of a related civil settlement, Chin personally agreed to pay $40,000. Even more damning, his wholly-owned company, KICVentures, will shell out a staggering $855,000. The total financial hit to Chin and his business empire is a hefty $9,500 fine for Chin, plus the $895,000 in settlements. This sends a clear message: concealing financial dealings within the healthcare system will not be tolerated.
The investigation was a collaborative effort, spearheaded by United States Attorney Leah B. Foley, and involving the U.S. Department of Health & Human Services’ Office of the Inspector General (Special Agent in Charge Roberto Coviello), the Federal Bureau of Investigation, Boston Division (Special Agent in Charge Ted E. Docks), the Veterans Affairs Office of Inspector General, Northeast Field Office (Special Agent in Charge Christopher Algieri), and the U.S. Postal Inspection Service’s Boston Division (Inspector in Charge Ketty Larco-Ward). Assistant U.S. Attorneys Abraham R. George, Christopher R. Looney, and Mackenzie A. Queenin were the prosecutors on the case.
This case is a stark reminder that even those at the highest levels of the medical device industry are subject to scrutiny. The deliberate falsification of reports to CMS isn’t just a paperwork issue; it undermines the integrity of the healthcare system and erodes public trust. For Dr. Kingsley Chin, the price of deception is a year of supervised release and a significant financial burden, a punishment that hopefully deters others from similar fraudulent practices.
Related Federal Cases
- Bacon Gets 6 Years for Mortgage Fraud Scheme · Massachusetts
- Andrew R. Bisignani Sentenced for Tax Fraud · Massachusetts
- Ballroom Boss Rouleau Hit With Tax Fraud Sentence · Massachusetts
- Old Con LaFrance Drowns in Fraud, Again · Massachusetts
- Mulcahey Sentenced for Union Fund & Tax Fraud · Massachusetts
Key Facts
- State: Massachusetts
- Agency: DOJ USAO
- Category: White Collar Crime
- Source: Official Source ↗
🔒 Get the grimiest stories delivered weekly. Subscribe free →
Browse More
MORE FEDERAL CRIME NEWS
White Collar CrimeWhite Collar CrimeWhite Collar CrimeWhite Collar Crime